Astrea has named Terry Pizzie as chief executive officer. Meanwhile, new officers join BIO’s governing board. Sit back, relax, and enjoy BioProcess Insider’s Ins & outs. Kick starting this week’s Ins & Out’s is Astrea Bioseparations (operating company of Gamma Biosciences), which has appointed Terry Pizzie to succeed Steve Burton as CEO. “Steve has been a key leader at Astrea Bioseparations since its early days as a spin out from the University of Cambridge and will continue as such in his new role…
